Theromics Inc

Theromics is leveraging next generation thermal accelerant technology to enhance soft tissue ablation procedures and more effectively deliver existing immunotherapy treatments. The company’s proprietary nanogels, HeatSYNC™ and CryoSYNC, are protein-based injectable nano-polymers that enhance the movement of energy in tissue, allowing more focused, precise ablations. Theromics was founded and spun out of Brown University in 2016 and is led by a team of accomplished clinicians, researchers and entrepreneurs committed to optimizing treatment strategies for a broad range of indications. “Caution: This device is for Investigational Use Only and has not been cleared by the FDA or other regulatory bodies.”